Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen Can't Stop Avastin Biosimilar 'Patent Dance' After Opting In, Genentech Says

Feb 18 2017

• By Brenda Sandburg

court house

Related Content

Biosimilars In 2017: Crowded US FDA Review Queue, Key Legal Decisions

Jan 24 2017

Supreme Court Should Pass On Zarxio, Wait For Another Biosimilar Suit, Amgen Says

Mar 24 2016

Related Companies

Genentech, Inc.

Amgen, Inc.

Roche Holding AG

Novartis AG

Allergan plc

Hospira, Inc.

Additional Topics

Policy Biosimilars Legal Issues BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window